Join the club for FREE to access the whole archive and other member benefits.

Cancer vaccines based on mRNA technology will be available soon


Key points from article :

Coronavirus vaccine is the work of BioNTech, a German company founded by Ugur Sahin and Ozlem Tureci.

Pfizer/BioNTech and Moderna vaccines use mRNA to send genetic instructions for making proteins to attack the coronavirus.

Same principle can be applied to get the immune system to take on tumours.

"We have several different cancer vaccines based on mRNA," - Ozlem Tureci, Chief medical officer, BioNTech.

"Within a couple of years, we will also have our vaccines (against) cancer at a place where we can offer them to people."

"It's the effort of many: our team, all the partners who were involved, also governments, regulatory authorities."

"The way we see it, this is an acknowledgement of this effort and also a celebration of science."

Value of BioNTech soaring to $21bn in the wake of the vaccine breakthrough.

Science behind developing Covid-19 vaccines could bring us cancer shots too

Mentioned in this article:

Click on resource name for more details.


Company developing patient-specific immunotherapies for cancer.

Ozlem Tureci

Co-Founder and Chief Medical Officer of BioNTech

Ugur Sahin

Professor Medicine at University of Mainz and Co-Founder and CEO of BioNTech.